Join
Live feed
·
PRReleasevia Quantisnow
Hyperfine Inc. logo

Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents

ByQuantisnow·Wall Street's wire, on your screen.
HYPR· Hyperfine Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HYPR (Hyperfine Inc.) and more on Quantisnow.